US20200071662A1 - Manufacturing Method and Device for Three-Dimensional Engineered Tissue - Google Patents
Manufacturing Method and Device for Three-Dimensional Engineered Tissue Download PDFInfo
- Publication number
- US20200071662A1 US20200071662A1 US16/677,735 US201916677735A US2020071662A1 US 20200071662 A1 US20200071662 A1 US 20200071662A1 US 201916677735 A US201916677735 A US 201916677735A US 2020071662 A1 US2020071662 A1 US 2020071662A1
- Authority
- US
- United States
- Prior art keywords
- support
- supports
- cell aggregates
- spheroids
- string members
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000004519 manufacturing process Methods 0.000 title description 27
- 210000004027 cell Anatomy 0.000 claims abstract description 179
- 210000003850 cellular structure Anatomy 0.000 claims abstract description 79
- 238000000034 method Methods 0.000 claims abstract description 73
- 238000012258 culturing Methods 0.000 claims abstract 3
- 239000000463 material Substances 0.000 claims description 22
- 239000011159 matrix material Substances 0.000 claims description 21
- 235000015097 nutrients Nutrition 0.000 claims description 7
- 239000000853 adhesive Substances 0.000 claims description 6
- 230000001070 adhesive effect Effects 0.000 claims description 6
- 238000005530 etching Methods 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims 4
- 230000000717 retained effect Effects 0.000 claims 2
- 230000008569 process Effects 0.000 description 29
- 230000001464 adherent effect Effects 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- 210000001519 tissue Anatomy 0.000 description 9
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 241000402754 Erythranthe moschata Species 0.000 description 4
- 238000005520 cutting process Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- 230000001413 cellular effect Effects 0.000 description 3
- 235000012489 doughnuts Nutrition 0.000 description 3
- 238000007667 floating Methods 0.000 description 3
- 230000035800 maturation Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 238000002054 transplantation Methods 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 230000004931 aggregating effect Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000021164 cell adhesion Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000007769 metal material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 238000000206 photolithography Methods 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 238000004080 punching Methods 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 231100000041 toxicology testing Toxicity 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000002449 bone cell Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000007910 cell fusion Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000003028 elevating effect Effects 0.000 description 1
- 238000004049 embossing Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000001459 lithography Methods 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0068—General culture methods using substrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3895—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M1/00—Apparatus for enzymology or microbiology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M27/00—Means for mixing, agitating or circulating fluids in the vessel
- C12M27/16—Vibrating; Shaking; Tilting
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0062—General methods for three-dimensional culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2513/00—3D culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2535/00—Supports or coatings for cell culture characterised by topography
Definitions
- This invention relates generally to the field of fabricating of three-dimensional engineered tissue using cell aggregates, especially the method of fabricating three-dimensional engineered tissue using the net-like shape or mesh-like supports.
- Tissue Engineering which utilizes living cell
- the ultimate goal of Tissue Engineering is to fabricate artificial tissue and organ for transplantation to human body. Artificial tissue is fabricated part of the body which expresses particular functionality when transplanted to human body.
- transplantation to human body requires number of approving process which comes with long span activities.
- engineered tissue as research specimen, which includes toxicity screening, drug effect judgement, pathology judgement, developmental research, etc.
- toxicity screening By fabricating engineered tissue with only human cells and using them for experimentation, it will be possible to reproduce or mimic in vivo environment of human body. This leads to higher drug discovery research, personalized medication diagnosis and development observations, etc.
- This technology may enable better prediction when text specimen is made with patient own cancer cells and tested number of different drugs ex-vivo, or outside of the body, prior to actual medications.
- Non-patent article 1 describes this cell aggregating phenomenon is known as old as 1960's.
- Non-patent article 6 clarifies the idea using cell aggregate as “Building Block” which indicates that diversified type of cell could be used.
- Japanese patent document JP-P4122280 describes a method of fabricating tissue plug from only living cell with desired shape without support. In detail, this process uses a chamber which possess micro-pore only at the bottom which enable medium to pass through, and apply just enough mediums inside of chamber so that part of cell aggregate are exposed to air, use in excess of medium of total chamber volume for maturation of cellular structure.
- U.S. Pat. No. 8,852,932 describes dispensing method which dispenses cell aggregate onto plane surface from printer nozzle
- PCT publication WO2017/150366 A1 shows a process needle array process which penetrates through Spheroids as needed.
- the needle array process use support consists of a number of needles mounted on base, which needles penetrate number of spheroids for alignment, and remove needles after the maturation to obtain 3D cellular structure.
- PCT publication WO2005/047496 shows process of making 3D Cellular structure by accumulating multiple plane cultured cell sheets which was made on permeable sheet.
- Embodiments of the invention relate generally to the field of fabricating of three-dimensional engineered tissue using cell aggregates, for example, a method of fabricating three-dimensional engineered tissue using net-like shape or mesh-like supports.
- this patent document claims to “arrange a plurality of cell aggregates according to a pattern such that each of the cell aggregates contacts at least one other cell aggregate,” which requires “arranging according to a pattern.” Also, as shape of these types of three-dimensional cellular structure depends largely on shape retaining capability of scaffold materials, there are limitation in size and shape (especially height direction). Furthermore, Scaffold will remain inside of three-dimensional Cellular structure, that leaves possibility of potential adverse effect against cell, which causes additional evaluation or approval process when transplanted to human patient.
- PCT publication WO/2017150366 describes a needle array process which has predetermined separation distance of each needle, several conditions toward cell aggregate are required, such as, cell aggregate has to be sphere shape in general, soft enough that needle can pierce through as well as hard enough that cell aggregate remain at the same position on the needle, and cell aggregate size has to be within certain range so that they shall be contacting each other on the needle. As this process picks a place cell aggregate one at a time, total operation time shall be considerably long. Furthermore, precise needle location is essential to this process and that requires precise manufacturing, which lead to higher manufacturing cost as well as special equipment to handle needle array.
- Embodiments of the present invention can solve the above mentioned problems and provide a better and easier method of fabricating three-dimensional cellular structure and supporting device ding the same.
- Embodiments provide a method of fabricating three-dimensional cellular structure.
- the method comprises a step of feeding cell aggregate onto thread or needle shaped members.
- the member forms meshed space by the thread or needle shaped members.
- the method also comprises a step of layering the supports with fed cell aggregate, and a step of removing the threads or needles from fused cellular structure.
- Embodiments also provide a method of fabricating cellular structure.
- the method comprises a step of layering supports having meshed space formed by thread or needle shaped members, a step of feeding cell aggregate onto the layered support, and a step of removing the thread or needle shape members from fused cellular structure.
- Embodiments also provide a method of fabricating cellular structure utilizing automated dispensing equipment.
- the method comprises a step of preparing support comprise multiple thread or needle shaped members which form net shaped space, a step of holding cell aggregates being fed from the automated dispensing equipment within the net shaped space after, and a step of removing thread or needle shaped member from fused cell aggregate.
- Embodiments also provide a method of making support described in present invention comprises forming a mask layer onto thin sheet member, and forming thread or needle shaped member by etching exposed area of the thin sheet member. Furthermore, a method of making support described in present invention comprises forming thread or needle shaped members by bonding wire.
- Embodiments of the present invention provide an easier fabrication method compared to existing methods, by enabling to remove thread or needle shaped member one by one from cell aggregate after the cell aggregates fused together, wherein the aggregate filled into the space which is formed by thread or needle shaped members.
- FIG. 1 provides a perspective view of first embodiment of support for three-dimensional cellular structure fabrication.
- FIG. 2 provides a plan view of the support shown in FIG. 1 .
- FIG. 3 provides a rear view of the support shown in FIG. 1 .
- FIG. 4 provides a perspective view of first embodiment of supports being layered.
- FIG. 5 provides an example of how first embodiment of support can be disassembled.
- FIG. 6 provides a schematic flow of fabrication process of three-dimensional cellular structure concerning the first embodiment of present invention.
- FIG. 7 shows how cell aggregate are being fed to support.
- FIG. 8 explains how cell aggregate are being dispensed by dispenser.
- FIG. 9 shows layering of supports which cell aggregate are already dispensed.
- FIG. 10 A shows schematic perspective view of three-dimensional cellular structure after frame of support.
- FIG. 10B shows schematic perspective view of three-dimensional cellular structure after thread shaped member are removed.
- FIG. 11 provides a one modification example of present invention, which shows dispensing after multiple supports are being layered.
- FIG. 12 provides a perspective view showing composition of support concerning the second embodiment of present invention.
- FIG. 12A provides a one modification example of second embodiment of present invention.
- FIG. 13 shows how cell aggregate are fed onto supports concerning second embodiment of present invention.
- FIG. 13A provides an example of how thread members are being removed after cutting supports.
- FIG. 14 provides a schematic perspective view of three-dimensional cellular structure fabricated using support concerning second embodiment of present invention.
- FIG. 15 shows composition of support concerning third embodiment of present invention.
- FIG. 16 provides a schematic perspective view of three-dimensional cellular structure fabricated using support concerning third embodiment of present invention.
- FIG. 17 shows modification of the third embodiment of present invention.
- FIG. 18 explains a fabrication method of three-dimensional cellular structure by the fourth embodiment of present invention.
- FIG. 19 explains a fabrication method of three-dimensional cellular structure by the fifth embodiment of present invention.
- FIG. 19A explains a fabrication method of three-dimensional cellular structure by the sixth embodiment of present invention.
- FIG. 20 provides a sectional view of support when manufactured by semiconductor manufacturing process.
- FIG. 20A shows sectional view of support when formed by bonding wire.
- FIG. 21 shows one example of manufacturing equipment for three-dimensional cellular structure concerning embodiment of present invention.
- FIG. 22 shows manufacturing process of support by 3D Printer concerning the sixth embodiment of present invention.
- a method of fabricating three-dimensional cellular structure as embodiment of present invention comprises providing a frame and a support with string members (thread or needle shaped) which form net shaped or matrix shaped space inside of the frame, filling the net shaped space with cell aggregate (Spheroid), and removing the string member from fused cellular aggregates to fabricate three-dimensional cellular structure.
- FIG. 1 is perspective view of first embodiment of support for three-dimensional cellular structure fabrication.
- FIG. 2 is plain view of the support shown in FIG. 1 .
- FIG. 3 is Rear view of the support shown in FIG. 1 .
- Support 1 comprises a frame 10 A, frame 10 B, frame 10 C, and frame 10 D forming four side of frame (called hereinafter frame 10 as a whole frame), multiple string member forming net or matrix shaped space inside of frame 10 , alignment measure to align each frame when layered.
- Frame 10 can be made of arbitrary materials, such as resin. Also, size of frame 10 can be any size, as an example one side length can be 3-4 cm and thickness can be 0.1-1.0 mm when cell aggregate size is around 200 um.
- String Member 20 exists in direction of X and Y inside of frame 10 .
- String member 20 can be made with materials such as stainless steel, nylon, polyester, and diameter can be 10 um as one example.
- Preferably string member 20 is coated with non-adhesive material such as P-HEMA, and sterilized with ethanol.
- String member 20 X existing in x direction connect to frame 10 A (by adhesive or such, for example) while another end connected to frame 10 C.
- String member 20 Y existing in Y direction connect to frame 10 A (by adhesive or such, for example) while another end connected to frame 10 C.
- Gap distance Px and Py can be 0.1 mm as an example.
- cell aggregates are dispensed onto string member 20 of support 1 , and dispensed cell aggregate has to be held at net shaped space formed by string member 20 .
- the size of net shaped space formed by string member 20 (Px, Py) has to be smaller than the size of cell aggregates to be dispensed.
- uniformity of cell aggregate size is not necessary. It should be noted that simply smallest size of cell aggregate Dmin needed to be larger than Px, Py. (Dmin>Px, Dmin>Py)
- Support 1 has alignment measure 30 to align each support when layered.
- Alignment measure 30 can be, but not limited to, dovetail fitting member, fastening by bolts, and other engaging measures.
- Figure shows cylindrical projections 30 A, projection 30 B, projection 30 C and projection 30 D are formed on each corner of support 1 , and recess 40 A, recess 40 B, recess 40 C and recess 40 D are formed on back side of support 1 which shall engaged to projections 30 A, projection 30 B, projection 30 C and projection respectively. Utilizing these projection 30 and recess 40 , layering multiple supports can be easily done.
- FIG. 4 shows an example of three supports, support 1 - 1 , support 1 - 2 and support 1 - 3 are being layered.
- height of projection 30 and/or depth of recess 40 By selecting height of projection 30 and/or depth of recess 40 , arbitrary space between supports can be obtained.
- FIG. 4B shows projection 30 height is smaller than the depth of recess 40 , which consequently forming space ⁇ d between support 1 - 1 and support 1 - 2 .
- Ad can be selected depending on thickness of support 1 and/or size of cell aggregate to be dispensed.
- FIG. 5(A) shows one example how frame is separated from the others.
- Frame 10 A has a recess 54 A on both ends; frame 10 C has a recess 52 B on both ends.
- frame 10 B has a projection 52 B on both ends and frame 10 D has a projection 52 D on both ends.
- Projection 52 B and 52 D, recess 54 A and 54 C engage each other respectively but also detachable.
- projection 52 B and 52 D engage to recess 54 A and 54 C respectively and four connected frame 10 will form rectangular shape support 1 .
- FIG. 5(B) shows other measure to separate frames. This measure is to separate four frames into two parts. Frame 10 A and 10 D remain engaged and frame 10 B and 10 C remain engaged. With this separating method, removal of string member 20 from three-dimensional cellular structure existing in x direction and Y direction is still possible.
- frames can be cut by knives, laser and such at multiple cutting locations to separate one frame from another frame, and also, cutting location can be between frame and string member. In this case, frame 10 cannot be reused.
- FIG. 7(A) shows one example how cell aggregate is filled into dispenser.
- Cell aggregate solution 100 which contains plurality of cell aggregate is filled into dispenser 200 .
- Cell aggregate size contained in cell aggregate solution 100 can be various, but minimum size of cell aggregate Dmin is larger than the space Px and Py width which formed by string member 20 .
- dispenser 200 comprise discharge part 210 and by manipulating cylinder 220 cell aggregate solution 100 can be discharged through discharge part 210 .
- Cell aggregate is dispensed onto support surface (S 104 ).
- support surface S 104
- cell aggregate 100 is dispensed onto string member 20 .
- Other way is to fix location of dispenser 200 , and mount support 1 on stage, and move stage 1 to x direction and y direction.
- the smallest size of cell aggregate Dmin dispensed onto support is larger than Px and Py width and yet dispensed cell aggregate does not go through string member 20 and held by string member 20 . It should be noted that part of sphere shape or orbital shape cell aggregate can be protrude through the space of Px, Py toward the bottom.
- FIG. 9(A) shows how cell aggregate solution 100 is dispensed onto support 1 - 1 and 1 - 2 , after completion of dispensing cell aggregate solution 100 onto support 1 - 2 , support 1 - 3 is layered on top of support 1 - 2 and cell aggregate solution 100 is dispensed.
- FIG. 9B shows how three support 1 - 1 , 1 - 2 and 1 - 3 are layered.
- layered support 1 with cell aggregate is dipped in container filled with medium.
- certain vibration or shake can be applied to support and/or container.
- Cell aggregate on support adhere and fuse together with cell aggregate contacting in horizontal direction.
- cell aggregates adhere and fuse together with cell aggregate on each layered support in vertical direction.
- sufficient nutrients and oxygen reach to cell aggregates.
- string member 20 lie in between cell aggregates on layered support, cell aggregate has access to nutrients and oxygen through the net shaped space. This condition brings ideal environment for cell adhesion and fusion. Time duration shall be determined depending on cell types.
- FIG. 10(A) shows schematic diagram of fused cell aggregate, which is three-dimensional cell aggregate 300 after all frames are separated.
- three-dimensional cell aggregate 300 is rectangular parallelepiped shape and possess in its inside multiple string member 20 X which lies in X direction and string member 20 Y which lies in Y direction, and these string member 20 X and string member 20 Y stick out from side of three-dimensional cellular structure.
- Next step is removal of string member from three-dimensional cellular structure (S 114 ).
- string member 20 X is removed in X direction
- string member 20 Y is removed in Y direction
- whole string member is completely removed from three-dimensional cellular structure.
- FIG. 10(B) is schematic diagram of three-dimensional cellular structure after removal of string member 20 .
- small pore 302 is formed on each side of three-dimensional cellular structure. These small pores 302 will be closed as cell aggregate adhere and fuse together in some time.
- FIG. 11(A) shows how support 1 are layered by n number
- FIG. 10(B) shows cell aggregate is dispensed onto from top of support 1 by dispenser 200 .
- gap distance of support string member Px and Py shall be decreased from top to the bottom.
- size of cell aggregate held by dispenser 200 can be any size between Px_min, Py_min ⁇ Px_max, Py_max. From these configurations, cell aggregate which pass through top layer string member space shall be caught by lower string member.
- net shaped space is formed on whole support area.
- net shaped space is formed according to arbitrary shape and size of three-dimensional cellular structure.
- FIG. 12 shows schematic diagram of support used for second embodiment.
- support 1 has string member 20 x in x direction is located in width Lx, and string member 20 y in y direction is located in width Ly. From this, support 1 has net shaped space only in between width Lx and Ly. Area 25 , which does not have string member, will not hold cell aggregate which is dispensed from dispencer 200 . Consequently, three-dimensional cellular structure is formed on Width Lx, Ly area.
- rectangular space Lx, Ly, but space shape can be different.
- multiple rectangular space S 1 , S 2 , S 3 and S 4 can be formed inside of support.
- four three-dimensional cellular structures which have corresponding shape to S 1 , S 2 , S 3 and S 4 are obtained at one process.
- multiple support shall be layered according to the height of designed three-dimensional cellular structure.
- FIG. 13 shows how supports are layered and cell aggregate are dispensed in second embodiment.
- FIG. 13(A) shows that supports 1 - 1 and 1 - 2 make an upper lid and supports 1 - 7 , 1 - 8 make a bottom lid.
- the number of Support 1 - 3 ⁇ 1 - 6 shall be determined by the height of designed three-dimensional cellular structure.
- Support 1 - 1 , 1 - 7 comprise multiple number of string member 20 X located in uniform gap distance in X direction
- Support 1 - 2 , 1 - 8 comprise multiple number of string member 20 Y located in uniform gap distance in Y direction.
- Support 1 - 3 comprise a pair of string member 22 X in x direction which regulate the x direction boundary of three-dimensional cellular structure
- Support 1 - 4 comprise a pair of string member 22 Y in y direction which regulate the y direction boundary of three-dimensional cellular structure.
- support 1 - 3 and 1 - 4 are layered by each other.
- cell aggregate is dispensed onto support with Upper Lidi- 1 , 1 - 2 detached. After dispensing is completed, upper Lid 1 - 1 1 - 2 is mounted onto Support 1 - 3 .
- FIG. 13(A) shows one example of how string member is removed.
- the support is cut at three CUT locations from top to bottom, and separate frame 10 B and 10 C from the body. And then, as shown on FIG. 13A (B), move remaining frame 10 A to X direction, and move remaining frame 10 D to Y direction so that all string member 20 is removed from three-dimensional cellular structure 300 .
- FIG. 14 is schematic perspective view of three-dimensional cellular structure fabricated by support described in second embodiment.
- Three-dimensional cellular structure 300 is fabricated at the size of space Lx and Ly which is regulated by string member in X direction and string member in Y direction.
- FIG. 15(A) is an example of guiding member 400 , and guiding member 400 provides triangle shape of length La, Lb and Lc.
- the height H of guiding member 400 also functions as spacer ⁇ d between support 1 when layered.
- Guiding member 400 is mounted onto support at fixed location as shown in FIG. 15(B) .
- Fixing measure can be various ways, as one example is to draw marking on support 1 and guiding member 400 is aligned onto support marking.
- Guiding member 400 can be connected lightly by other fixture or adhesives, or simply placed on the support. Also, preferably guiding member surface s coated with non-adherent material for easy removal from cell aggregate.
- dispense 200 dispense cell aggregate into the space guided by guiding member 400 .
- other support is layered and guiding support 400 is also placed, and cell aggregate is dispensed into as well. Consequently as shown in FIG. 16 , Three-dimensional cellular structure 300 is obtained.
- the above example used a triangle shape guiding member, and the shape can be others such as circle, donuts, rectangular, oval etc.
- the shape can be others such as circle, donuts, rectangular, oval etc.
- donuts shape guiding member 41 when donuts shape guiding member 41 is used, donuts shaped three-dimensional cellular structure is obtained.
- Embodiment 1-3 used dispenser to fill in cell aggregate onto supports, while fourth embodiment use process to filter out cell aggregate in solution by support.
- FIG. 18 One example is shown in FIG. 18 .
- solution containing cell aggregate 100 is held in a container, support 1 filters out cell aggregate from solution. From this procedure, cell aggregate larger than the size of net shaped space of string member 20 is filtered out onto string member.
- FIG. 19 shows example of embodiment.
- Prepare string member which is capable to form net shaped space as shown on FIG. 19(A)
- Mold 450 can be any shape, and this example has rectangular shape mold 452 .
- Mold 450 can be made by various process, and this can be made by plastic injection process. It is also possible to form mold 450 by laser processing, punching process.
- string member 20 is formed along the boundary of inner space 450 .
- cell aggregate 100 is dispensed into inner space 452 of mold 450 by dispenser.
- lid formed by string member 20 , and placed onto mold 450 . This lid prevents cell aggregate from spilling out from mold when shaken inside of solution with medium.
- string member 20 is lifted up from mold 450 and cell aggregate 100 is removed from mold 450 .
- Three-dimensional cellular aggregate 460 which reflect the shape of mold 450 is obtained by removing string member 20 .
- string member 20 is made with non-adherent material, or its surface is coated by non-adherent material, so that removal of string member 20 from cell aggregate 100 is easier.
- automated-dispenser comprise stage 470 , reference guide 472 (x direction) and guide 474 (y direction), a pair of moving tower 480 which moves in x direction, bridging member 482 which connect between tower 480 in y direction, sliding member 484 which is movable to Y and Z direction, dispenser 490 and plunger 492 attached on sliding member 484 .
- Dispenser 490 will be filled with cell aggregate 100 , as plunger 492 is actuated in Z direction so that cell aggregate 100 is extruded from tip of dispenser 490 .
- Automated dispenser is pre-programmed of the shape of support 1 and the initial filling point of cell aggregate, and automated dispenser scan in X, Y, Z direction according to the three-dimensional data of three-dimensional cellular structure to be made.
- dispenser 490 scan in direction of X and Y, simultaneously plunger 492 is actuated, cell aggregate is extruded onto support from tip of dispenser 490 .
- plunger 492 is actuated, cell aggregate is extruded onto support from tip of dispenser 490 .
- another support is layered and again cell aggregate is dispensed according to three-dimensional data.
- This embodiment enable fast dispensing of cell aggregate onto supports.
- Support 1 comprises, for example, rectangular frame 10 .
- Support 1 can be any shape and size, and space surrounded by frame 10 is further divided into smaller spaces by string member 20 .
- String Member 20 consists of thread or needle shaped member and end of string member 20 is adhered or fixed in other way to frame.
- FIG. 20 shows schematic cross-sectional view of the process. As shown in FIG. 20(A) , place thin material 510 which will become support onto resin film 500 such as UV cured type, and patterned musk 520 is formed by photo-lithography process, Musk 520 is designed so that gap distance Px, Py form matrix shape.
- resin film 500 such as UV cured type
- patterned musk 520 is formed by photo-lithography process
- Musk 520 is designed so that gap distance Px, Py form matrix shape.
- FIG. 20(B) shows that exposed areas of thin material 510 are removed by an etching process.
- Anisotropic etching process is preferred for accuracy. Etching process can be either wet or dry process.
- musk 520 is removed and then as shown in FIG. 20(D) resin film 500 is removed by exposing to UV light.
- integrated support 1 comprising frame 10 and string member 20 as one is fabricated.
- musk 520 fabrication method can be other method such as laser processing.
- cavity with gap distance Px, Py can be formed by laser processing onto thin material to form support.
- punching process can be used to form cavity onto thin material by applying embossing member with Px, Py shaped pattern.
- 3D printer can be used to from integrated support with frame and string member as one by resin materials.
- FIG. 20A is schematic cross-sectional view when string member is formed by bonding wires.
- base 550 is prepared first.
- Base 550 is made with metal material such as stainless steel.
- Base 520 comprise outer frame 552 and center net area which comprise multiple opening 524 .
- opening 554 can be made by etching process on base 550 .
- frame 560 A and 560 C with level step in its inside are formed.
- Frame 560 A and 560 C are equivalent to frame 10 A, 10 C of FIG. 1 , respectively.
- Frame 560 A and 560 C possess 4 level steps equivalent to 4 layers of supports.
- bonding wire B- 1 runs in X and Y directions
- bonding wire B- 2 runs in X and Y directions
- bonding wire B- 3 runs in X and Y directions
- bonding wire B- 4 runs in X and Y directions.
- top lid 570 can be used. This top lid can be same as base 550 .
- FIG. 21 is a block chart of electrical structure of equipment used for three-dimensional cellular structure fabrication.
- Equipment 600 comprise interface 610 which enable input from operator and connection between equipment and peripheral equipment, memory 620 which stores data and program, controller 630 , and actuator 640 which drives dispenser 200 .
- Memory 620 comprise program for fabrication process to fabricate three-dimensional cellular structure, controller 630 conduct the program to fabricate three-dimensional cellular structure.
- memory 620 stores 3D data of three-dimensional cellular structure, controller 630 controls scanning track of dispenser 200 .
- the dispenser provides the shape of cell aggregates on the support based on 3D data.
- the shape of each layer of support is determined by 3D data.
- dispenser 200 deliver cell aggregate in different shapes, which is smaller and smaller, on each layer.
- actuator 640 moves stage to X and Y direction to dispense cell aggregate onto supports.
- FIG. 22 shows how 3D support is made by 3D Printer.
- this 3D support is called as mold 700 .
- Mold 700 is made with non-toxic material to human being.
- mold 700 is made with material such as polycarbonate which has high melting temperature for high temperature sterilization.
- mold 700 is coated with non-adherent material to prevent cell adhesion to mold.
- Mold 700 comprise, as shown in FIG. 22(A) , upper part 710 and lower part 720 .
- Upper part 710 and lower part 720 possess net shaped area where cell aggregates are held and they are made by 3D printer.
- mold 700 is separated to upper part 710 and lower part 720 at cutting position Dv.
- Upper part 710 comprises top and side members. Multiple filling holes 702 are connected to the inner space on the top member. Also, a side of upper part 710 has multiple circulation holes 704 for medium flow. Upper part 710 comprises column support 706 which extend from top, and multiple support columns 706 are connected to upper net shaped members 708 which form three-dimensional space. Lower part 720 comprise column support 714 which extend from bottom, and multiple support column 714 are connected to lower net shaped member 716 which form three-dimensional space
- Cell aggregate 100 is filled in through filling hole 702 .
- the gap distance of upper net shaped member 708 is larger than the size of cell aggregate but the gap distance of lower net shaped member 716 is smaller than the size of cell aggregate so that cell aggregate pass through upper net shaped member 708 and trapped by lower net shaped member 716 . It needed to be noted that this is one example and gap distance of upper net shaped member 708 and lower net shaped member can be the same.
- mold 700 with cell aggregates filled is soaked in container 720 filled with medium 730 .
- medium 730 shall circulate through filling hole 702 and circulating holes 704 and 714 , which enable effective culture of cells.
- mold 700 is separated to upper part 710 and lower part 720 , and three-dimensional cellular structure is obtained.
- String member 20 used by embodiment 1-6 are made of either adherent or non-adherent materials.
- string member 20 is made with non-adherent material for easy removal, coated with non-adherent material otherwise.
- Cell aggregate used by embodiment 1-3 are consists of either single cell type or multiple cell types. When multiple cell types are used, obtained three-dimensional cellular structure comprise multiple cell type.
- Three-dimensional cellular structure made by embodiment 1-5 are used for medical and research purpose, as well as potential application of joint regeneration, toxicity screening, cancer research, neural regeneration, cardiovascular regeneration, as such.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Sustainable Development (AREA)
- Developmental Biology & Embryology (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
- This application is a continuation of co-pending International Application No. PCT/JP2016/076987, which was filed on Sep. 13, 2016 and is incorporated herein by reference.
- This invention relates generally to the field of fabricating of three-dimensional engineered tissue using cell aggregates, especially the method of fabricating three-dimensional engineered tissue using the net-like shape or mesh-like supports.
- As world population increases as well as prolonged human lifetime span, needs, desires and demands for medical treatments are only elevating. In recent years, a new approach, Tissue Engineering, which utilizes living cell, is spotlighted. The ultimate goal of Tissue Engineering is to fabricate artificial tissue and organ for transplantation to human body. Artificial tissue is fabricated part of the body which expresses particular functionality when transplanted to human body. However, transplantation to human body requires number of approving process which comes with long span activities.
- Aside from human transplantation, another promising application is to use engineered tissue as research specimen, which includes toxicity screening, drug effect judgement, pathology judgement, developmental research, etc. By fabricating engineered tissue with only human cells and using them for experimentation, it will be possible to reproduce or mimic in vivo environment of human body. This leads to higher drug discovery research, personalized medication diagnosis and development observations, etc.
- Especially in the field of cancer, medication diagnosis and effect prediction is always difficult one. This technology may enable better prediction when text specimen is made with patient own cancer cells and tested number of different drugs ex-vivo, or outside of the body, prior to actual medications.
- There are two types of cells, one is floating cell and another is adherent cell which required scaffold. Floating cell includes blood cells and immune system, and adherent cell are organ, skin and bone cells. Adherent cell shall not be able to survive in long period when floating in cell suspension, and it is necessary to let them adhere to any scaffold such as dish or gel and such so that they can survive and proliferate. When adherent cell is located in non-adherent environment, which means there are nothing to adhere to, cells seek for scaffold and start adhering each other and consequently forms large cell aggregate, which is three-dimensional cellular structure. This phenomenon is widely known and reported in
non-patent articles 1˜6. Non-patentarticle 1 describes this cell aggregating phenomenon is known as old as 1960's. Especially non-patent article 6 clarifies the idea using cell aggregate as “Building Block” which indicates that diversified type of cell could be used. - Japanese patent document JP-P4122280 describes a method of fabricating tissue plug from only living cell with desired shape without support. In detail, this process uses a chamber which possess micro-pore only at the bottom which enable medium to pass through, and apply just enough mediums inside of chamber so that part of cell aggregate are exposed to air, use in excess of medium of total chamber volume for maturation of cellular structure.
- Also, there are number of methods of making three-dimensional cellular structure. U.S. Pat. No. 8,852,932 describes dispensing method which dispenses cell aggregate onto plane surface from printer nozzle, whereas PCT publication WO2017/150366 A1 (PCT/JP2017/007029) shows a process needle array process which penetrates through Spheroids as needed. The needle array process use support consists of a number of needles mounted on base, which needles penetrate number of spheroids for alignment, and remove needles after the maturation to obtain 3D cellular structure. Furthermore, PCT publication WO2005/047496 shows process of making 3D Cellular structure by accumulating multiple plane cultured cell sheets which was made on permeable sheet.
- The following non-patent literature is also related to subject matter disclosed herein:
- PLOS ONE, Journal. Pone. 0136681, “Scaffold-Free Tubular Tissues Created by a Bio-3D printer Undergo Remolding and Endothelialization when Implanted in Rat Aortae,” Manabu Itoh et al, Sep. 1, 2015;
- Gordon R, Goel N S, Steinberg M S, Wiseman L L. A rheological mechanism sufficient to explain the kinetics of cell sorting. J Theor Biol. 1972; 37:43-73. [Pub Med: 4652421];
- Jakab K, Damon B, Marga F, Doaga O, Mironov V, Kosztin I, Markwald R, Forgacs G. Relating cell and tissue mechanics: implications and applications. Dev. Dyn. 2008; 237:2438-2449. [PubMed: 1872 9216];
- Jakab K, Neagu A, Mironov V, Markwald R R, Forgacs G. Engineering biological structures of prescribed shape using self-assembling multicellular systems. Proc Natl Acad Sci USA. 2004; 101:2864-2869. [PubMed: 14981244];
- Perez-Pomares J M, Foty R A. Tissue fusion and cell sorting in embryonic development and disease: biomedical implications. Bioessays. 2006; 28:809-821. [PubMed: 16927301]; and
- Organ printing: Tissue spheroids as building blocks” Biomaterials. Vladimir Mironov, Richard P. Visconti, Vladimir Kasynocv, Gabor Forgacs, Christopher J. Drake, and Roger R. Markwald, 2009 April; 30(12):2164-2174. doi:10.1016.
- Embodiments of the invention relate generally to the field of fabricating of three-dimensional engineered tissue using cell aggregates, for example, a method of fabricating three-dimensional engineered tissue using net-like shape or mesh-like supports.
- Most dispensing methods for three-dimensional cellular structure fabrication such as described in U.S. Pat. No. 8,852,932 are either a process which dispense Bio-Ink, which consists of spheroid and connecting material such as Hydrogel or collagen, onto flat surface, or a process injecting spheroids into pre-build scaffold made with shape maintaining material which can be Hydrogel or Collagen. The downside of this method is that scaffold material block oxygen and nutrients delivery to cells. Furthermore, this patent document claims to “arrange a plurality of cell aggregates according to a pattern such that each of the cell aggregates contacts at least one other cell aggregate,” which requires “arranging according to a pattern.” Also, as shape of these types of three-dimensional cellular structure depends largely on shape retaining capability of scaffold materials, there are limitation in size and shape (especially height direction). Furthermore, Scaffold will remain inside of three-dimensional Cellular structure, that leaves possibility of potential adverse effect against cell, which causes additional evaluation or approval process when transplanted to human patient.
- PCT publication WO/2017150366 describes a needle array process which has predetermined separation distance of each needle, several conditions toward cell aggregate are required, such as, cell aggregate has to be sphere shape in general, soft enough that needle can pierce through as well as hard enough that cell aggregate remain at the same position on the needle, and cell aggregate size has to be within certain range so that they shall be contacting each other on the needle. As this process picks a place cell aggregate one at a time, total operation time shall be considerably long. Furthermore, precise needle location is essential to this process and that requires precise manufacturing, which lead to higher manufacturing cost as well as special equipment to handle needle array.
- Embodiments of the present invention can solve the above mentioned problems and provide a better and easier method of fabricating three-dimensional cellular structure and supporting device ding the same.
- Embodiments provide a method of fabricating three-dimensional cellular structure. The method comprises a step of feeding cell aggregate onto thread or needle shaped members. The member forms meshed space by the thread or needle shaped members. The method also comprises a step of layering the supports with fed cell aggregate, and a step of removing the threads or needles from fused cellular structure.
- Embodiments also provide a method of fabricating cellular structure. The method comprises a step of layering supports having meshed space formed by thread or needle shaped members, a step of feeding cell aggregate onto the layered support, and a step of removing the thread or needle shape members from fused cellular structure.
- Embodiments also provide a support used for three-dimensional cellular structure in present invention comprises multiple frames, multiple thread or needle shaped members which form net shaped space surrounded by multiple frames, and the net shaped space can hold cell aggregates.
- Embodiments also provide a method of fabricating cellular structure utilizing automated dispensing equipment. The method comprises a step of preparing support comprise multiple thread or needle shaped members which form net shaped space, a step of holding cell aggregates being fed from the automated dispensing equipment within the net shaped space after, and a step of removing thread or needle shaped member from fused cell aggregate.
- Embodiments also provide a method of making support described in present invention comprises forming a mask layer onto thin sheet member, and forming thread or needle shaped member by etching exposed area of the thin sheet member. Furthermore, a method of making support described in present invention comprises forming thread or needle shaped members by bonding wire.
- Embodiments of the present invention provide an easier fabrication method compared to existing methods, by enabling to remove thread or needle shaped member one by one from cell aggregate after the cell aggregates fused together, wherein the aggregate filled into the space which is formed by thread or needle shaped members.
-
FIG. 1 provides a perspective view of first embodiment of support for three-dimensional cellular structure fabrication. -
FIG. 2 provides a plan view of the support shown inFIG. 1 . -
FIG. 3 provides a rear view of the support shown inFIG. 1 . -
FIG. 4 provides a perspective view of first embodiment of supports being layered. -
FIG. 5 provides an example of how first embodiment of support can be disassembled. -
FIG. 6 provides a schematic flow of fabrication process of three-dimensional cellular structure concerning the first embodiment of present invention. -
FIG. 7 shows how cell aggregate are being fed to support. -
FIG. 8 explains how cell aggregate are being dispensed by dispenser. -
FIG. 9 shows layering of supports which cell aggregate are already dispensed. -
FIG. 10 A shows schematic perspective view of three-dimensional cellular structure after frame of support. -
FIG. 10B shows schematic perspective view of three-dimensional cellular structure after thread shaped member are removed. -
FIG. 11 provides a one modification example of present invention, which shows dispensing after multiple supports are being layered. -
FIG. 12 provides a perspective view showing composition of support concerning the second embodiment of present invention. -
FIG. 12A provides a one modification example of second embodiment of present invention. -
FIG. 13 shows how cell aggregate are fed onto supports concerning second embodiment of present invention. -
FIG. 13A provides an example of how thread members are being removed after cutting supports. -
FIG. 14 provides a schematic perspective view of three-dimensional cellular structure fabricated using support concerning second embodiment of present invention. -
FIG. 15 shows composition of support concerning third embodiment of present invention. -
FIG. 16 provides a schematic perspective view of three-dimensional cellular structure fabricated using support concerning third embodiment of present invention. -
FIG. 17 shows modification of the third embodiment of present invention. -
FIG. 18 explains a fabrication method of three-dimensional cellular structure by the fourth embodiment of present invention. -
FIG. 19 explains a fabrication method of three-dimensional cellular structure by the fifth embodiment of present invention. -
FIG. 19A explains a fabrication method of three-dimensional cellular structure by the sixth embodiment of present invention. -
FIG. 20 provides a sectional view of support when manufactured by semiconductor manufacturing process. -
FIG. 20A shows sectional view of support when formed by bonding wire. -
FIG. 21 shows one example of manufacturing equipment for three-dimensional cellular structure concerning embodiment of present invention. -
FIG. 22 shows manufacturing process of support by 3D Printer concerning the sixth embodiment of present invention. - A method of fabricating three-dimensional cellular structure as embodiment of present invention comprises providing a frame and a support with string members (thread or needle shaped) which form net shaped or matrix shaped space inside of the frame, filling the net shaped space with cell aggregate (Spheroid), and removing the string member from fused cellular aggregates to fabricate three-dimensional cellular structure.
- Below are explanations of embodiments.
FIG. 1 is perspective view of first embodiment of support for three-dimensional cellular structure fabrication.FIG. 2 is plain view of the support shown inFIG. 1 .FIG. 3 is Rear view of the support shown inFIG. 1 .Support 1 comprises aframe 10A,frame 10B, frame 10C, and frame 10D forming four side of frame (called hereinafterframe 10 as a whole frame), multiple string member forming net or matrix shaped space inside offrame 10, alignment measure to align each frame when layered. -
Frame 10 can be made of arbitrary materials, such as resin. Also, size offrame 10 can be any size, as an example one side length can be 3-4 cm and thickness can be 0.1-1.0 mm when cell aggregate size is around 200 um. -
String Member 20 exists in direction of X and Y inside offrame 10.String member 20 can be made with materials such as stainless steel, nylon, polyester, and diameter can be 10 um as one example. Preferablystring member 20 is coated with non-adhesive material such as P-HEMA, and sterilized with ethanol.String member 20X existing in x direction connect to frame 10A (by adhesive or such, for example) while another end connected to frame 10C.String member 20Y existing in Y direction connect to frame 10A (by adhesive or such, for example) while another end connected to frame 10C.Multiple String member 20X in x direction are placed at uniform gap distance Px, andmultiple String member 20Y in y direction are placed at uniform gap distance Py, consequently both members forming rectangular shaped spaces of Px and Py inside offrame 10. Gap distance Px and Py can be 0.1 mm as an example. Also, ratio of Px and Py can be determined by aspect ratio of frame 10 (for example, Px:Py=4. When aspect ratio offrame 10 is 4:3) but not limited to this ratio. - As explained later, cell aggregates are dispensed onto
string member 20 ofsupport 1, and dispensed cell aggregate has to be held at net shaped space formed bystring member 20. Thus, the size of net shaped space formed by string member 20 (Px, Py) has to be smaller than the size of cell aggregates to be dispensed. However, uniformity of cell aggregate size is not necessary. It should be noted that simply smallest size of cell aggregate Dmin needed to be larger than Px, Py. (Dmin>Px, Dmin>Py) - As one of good examples, in order to fabricate three-dimensional cellular structure, identical shaped number of
support 1 are layered as shown inFIG. 4(A) .Support 1 has alignment measure 30 to align each support when layered. Alignment measure 30 can be, but not limited to, dovetail fitting member, fastening by bolts, and other engaging measures. Figure showscylindrical projections 30A,projection 30B,projection 30C andprojection 30D are formed on each corner ofsupport 1, andrecess 40A,recess 40B, recess 40C andrecess 40D are formed on back side ofsupport 1 which shall engaged toprojections 30A,projection 30B,projection 30C and projection respectively. Utilizing these projection 30 and recess 40, layering multiple supports can be easily done.FIG. 4 shows an example of three supports, support 1-1, support 1-2 and support 1-3 are being layered. By selecting height of projection 30 and/or depth of recess 40, arbitrary space between supports can be obtained.FIG. 4B shows projection 30 height is smaller than the depth of recess 40, which consequently forming space Δd between support 1-1 and support 1-2. Ad can be selected depending on thickness ofsupport 1 and/or size of cell aggregate to be dispensed. - Preferably one of the frames out of multiple frames is detachable from other frames. As explained later, this makes removal of
string member 20 from fused sell aggregate easier after cell aggregate fused together.FIG. 5(A) shows one example how frame is separated from the others.Frame 10A has arecess 54A on both ends; frame 10C has arecess 52B on both ends. Also,frame 10B has aprojection 52B on both ends andframe 10D has aprojection 52D on both ends. 52B and 52D,Projection 54A and 54C engage each other respectively but also detachable. When cell aggregate is dispensed,recess 52B and 52D engage to recess 54A and 54C respectively and fourprojection connected frame 10 will formrectangular shape support 1. Later when string member is removed from three-dimensional cellular structure, 52B and 52D,projection 54A and 54C are detached, consequently makes four frames separable. Also, when four frames to are separated, connection betweenrecess string member 20 andframe 10 can be released. For example,string member 20 pulled out offrame 10 fixture, and/or cut by knives. -
FIG. 5(B) shows other measure to separate frames. This measure is to separate four frames into two parts. 10A and 10D remain engaged andFrame frame 10B and 10C remain engaged. With this separating method, removal ofstring member 20 from three-dimensional cellular structure existing in x direction and Y direction is still possible. - Nevertheless, the separating method of the frames is not limited to as described in
FIG. 5 . For example, whenframe 10 is made with soft and easily cuttable materials, frames can be cut by knives, laser and such at multiple cutting locations to separate one frame from another frame, and also, cutting location can be between frame and string member. In this case,frame 10 cannot be reused. - Next, method of three-dimensional cellular
structure using support 1 is described usingFIG. 6 . First, make cell aggregate (Spheroid) in range of certain size by aggregating plurality of living cell (S100). Method of making cell aggregate can be any measure, and one example is described inPatent Document 3. - After making cell aggregate, cell aggregate is filled into dispenser (S102).
FIG. 7(A) shows one example how cell aggregate is filled into dispenser.Cell aggregate solution 100 which contains plurality of cell aggregate is filled intodispenser 200. Cell aggregate size contained in cellaggregate solution 100 can be various, but minimum size of cell aggregate Dmin is larger than the space Px and Py width which formed bystring member 20. As shown inFIG. 7(B) ,dispenser 200 comprisedischarge part 210 and by manipulatingcylinder 220 cellaggregate solution 100 can be discharged throughdischarge part 210. - Next, Cell aggregate is dispensed onto support surface (S104). As shown in
FIG. 8 , by scanning to X and Y directions according to desired shape of three-dimensional cellular structure,cell aggregate 100 is dispensed ontostring member 20. Other way is to fix location ofdispenser 200, and mountsupport 1 on stage, and movestage 1 to x direction and y direction. The smallest size of cell aggregate Dmin dispensed onto support is larger than Px and Py width and yet dispensed cell aggregate does not go throughstring member 20 and held bystring member 20. It should be noted that part of sphere shape or orbital shape cell aggregate can be protrude through the space of Px, Py toward the bottom. - Next, number of layer is monitored (S106). Number of layer is determined by Z axis height of three-dimensional cellular structure to be fabricated. Until given number of layer is completed, additional support is layered (S108) and cell aggregate solution is dispensed onto (S104). When support is layered, each support is aligned by alignment measure 30 and 40,
FIG. 9(A) shows how cellaggregate solution 100 is dispensed onto support 1-1 and 1-2, after completion of dispensing cellaggregate solution 100 onto support 1-2, support 1-3 is layered on top of support 1-2 and cellaggregate solution 100 is dispensed. Thus, multiple supports are layered and cellaggregate solution 100 is dispensed depending on the size of three-dimensional cellular structure to be fabricated.FIG. 9B shows how three support 1-1,1-2 and 1-3 are layered. When multiple supports are layered, a part of cell aggregate dispensed on upper support can protrude from net space gap downward and have contact to part of cell aggregate dispensed onto lower support. - When a designated number of supports are layered, dispensing cell aggregate solution finishes and they are dipped into medium suitable for cell culture so that cell aggregate fuse together (S110). For example,
layered support 1 with cell aggregate is dipped in container filled with medium. At that time, certain vibration or shake can be applied to support and/or container. Cell aggregate on support adhere and fuse together with cell aggregate contacting in horizontal direction. Also, cell aggregates adhere and fuse together with cell aggregate on each layered support in vertical direction. As there is no obstacle to block nutrients and oxygen delivery between cell aggregates dispensed on one support, sufficient nutrients and oxygen reach to cell aggregates. Also, as onlystring member 20 lie in between cell aggregates on layered support, cell aggregate has access to nutrients and oxygen through the net shaped space. This condition brings ideal environment for cell adhesion and fusion. Time duration shall be determined depending on cell types. - After adhesion and fusion of cell aggregate is completed, frame of layered supports is separated (S112). When separating frames, as of
FIGS. 5(A) and (B), part or whole frame can be separated, or one end ofstring member 20 is separated or cut by knives or laser.FIG. 10(A) shows schematic diagram of fused cell aggregate, which is three-dimensional cell aggregate 300 after all frames are separated. On this schematic diagram, three-dimensional cell aggregate 300 is rectangular parallelepiped shape and possess in its insidemultiple string member 20X which lies in X direction andstring member 20Y which lies in Y direction, and thesestring member 20X andstring member 20Y stick out from side of three-dimensional cellular structure. - Next step is removal of string member from three-dimensional cellular structure (S114). Preferably, from three-dimensional cellular structure shown in
FIG. 10(A) ,string member 20X is removed in X direction, andstring member 20Y is removed in Y direction, whole string member is completely removed from three-dimensional cellular structure.FIG. 10(B) is schematic diagram of three-dimensional cellular structure after removal ofstring member 20. On each side of three-dimensional cellular structure, there aresmall pore 302 as the result of removal ofstring member 20. Thesesmall pores 302 will be closed as cell aggregate adhere and fuse together in some time. - As described with respect to the above embodiment, using support which net shaped space is formed inside, dispensing cell aggregate into net shaped space, layer these supports with dispensed cell aggregate, and then removing string member from adhered and/or fused cell aggregate, it is made easier to form plan three-dimensional cellular structure in X and Y direction on one support, and also it is made easier to form thicker three-dimensional cellular structure by layering support in Z direction. Also, cell aggregates are held by very thin
diameter string member 20, which blockage of nutrients and oxygen is minimal. Furthermore, string members will be removed from three-dimensional cellular structure, obtained three-dimensional cellular structure does not contain any foreign substance and consequently consists of only required cells. - The above embodiment explained one procedure which cell aggregate is dispensed onto one support and then layered multiple supports, but other procedure is possible such as layering only supports with no cell aggregate is dispensed first, and then dispense cell aggregate onto layered supports.
FIG. 11(A) shows howsupport 1 are layered by n number, andFIG. 10(B) shows cell aggregate is dispensed onto from top ofsupport 1 bydispenser 200. Preferably, when this procedure is done, gap distance of support string member Px and Py shall be decreased from top to the bottom. When gap distance of top support string member is Px_max, Py_max, and gap distance of bottom support string member is Px_min, Py_min, size of cell aggregate held bydispenser 200 can be any size between Px_min, Py_min˜Px_max, Py_max. From these configurations, cell aggregate which pass through top layer string member space shall be caught by lower string member. - Next a second embodiment of present invention is explained. In the first embodiment, net shaped space is formed on whole support area. In the second embodiment, net shaped space is formed according to arbitrary shape and size of three-dimensional cellular structure.
-
FIG. 12 shows schematic diagram of support used for second embodiment. In this embodiment,support 1 has string member 20 x in x direction is located in width Lx, and string member 20 y in y direction is located in width Ly. From this,support 1 has net shaped space only in between width Lx and Ly.Area 25, which does not have string member, will not hold cell aggregate which is dispensed fromdispencer 200. Consequently, three-dimensional cellular structure is formed on Width Lx, Ly area. - The above mentioned example used rectangular space Lx, Ly, but space shape can be different. For example, as shown in
FIG. 12(A) , multiple rectangular space S1, S2, S3 and S4 can be formed inside of support. In this case, four three-dimensional cellular structures which have corresponding shape to S1, S2, S3 and S4 are obtained at one process. - In second embodiment as well as used in first embodiment, multiple support shall be layered according to the height of designed three-dimensional cellular structure.
FIG. 13 shows how supports are layered and cell aggregate are dispensed in second embodiment. -
FIG. 13(A) shows that supports 1-1 and 1-2 make an upper lid and supports 1-7, 1-8 make a bottom lid. The number of Support 1-3˜1-6 shall be determined by the height of designed three-dimensional cellular structure. Support 1-1,1-7 comprise multiple number ofstring member 20X located in uniform gap distance in X direction, and Support 1-2,1-8 comprise multiple number ofstring member 20Y located in uniform gap distance in Y direction. Support 1-3 comprise a pair ofstring member 22X in x direction which regulate the x direction boundary of three-dimensional cellular structure, and Support 1-4 comprise a pair ofstring member 22Y in y direction which regulate the y direction boundary of three-dimensional cellular structure. Preferably, support 1-3 and 1-4 are layered by each other. Next, as shown onFIG. 3(B) , cell aggregate is dispensed onto support with Upper Lidi-1, 1-2 detached. After dispensing is completed, upper Lid 1-1 1-2 is mounted onto Support 1-3. -
FIG. 13(A) shows one example of how string member is removed. As shown onFIG. 13A (A), the support is cut at three CUT locations from top to bottom, andseparate frame 10B and 10C from the body. And then, as shown onFIG. 13A (B), move remainingframe 10A to X direction, and move remainingframe 10D to Y direction so that allstring member 20 is removed from three-dimensionalcellular structure 300. -
FIG. 14 is schematic perspective view of three-dimensional cellular structure fabricated by support described in second embodiment. Three-dimensionalcellular structure 300 is fabricated at the size of space Lx and Ly which is regulated by string member in X direction and string member in Y direction. - Next, the third embodiment is described. At the third embodiment, guiding member which regulate the shape of cell aggregates to be dispensed into, is provided on a support.
FIG. 15(A) is an example of guidingmember 400, and guidingmember 400 provides triangle shape of length La, Lb and Lc. The height H of guidingmember 400 also functions as spacer Δd betweensupport 1 when layered. Guidingmember 400 is mounted onto support at fixed location as shown inFIG. 15(B) . Fixing measure can be various ways, as one example is to draw marking onsupport 1 and guidingmember 400 is aligned onto support marking. Guidingmember 400 can be connected lightly by other fixture or adhesives, or simply placed on the support. Also, preferably guiding member surface s coated with non-adherent material for easy removal from cell aggregate. - As shown in
FIG. 15(B) , dispense 200 dispense cell aggregate into the space guided by guidingmember 400. Next, other support is layered and guidingsupport 400 is also placed, and cell aggregate is dispensed into as well. Consequently as shown inFIG. 16 , Three-dimensionalcellular structure 300 is obtained. - The above example used a triangle shape guiding member, and the shape can be others such as circle, donuts, rectangular, oval etc. For example, as shown in
FIG. 17(A) , when donuts shape guiding member 41 is used, donuts shaped three-dimensional cellular structure is obtained. - Next, fourth embodiment of present invention is explained. Embodiment 1-3 used dispenser to fill in cell aggregate onto supports, while fourth embodiment use process to filter out cell aggregate in solution by support. One example is shown in
FIG. 18 . As shown in this figure, solution containingcell aggregate 100 is held in a container,support 1 filters out cell aggregate from solution. From this procedure, cell aggregate larger than the size of net shaped space ofstring member 20 is filtered out onto string member. - In the case of supports with uniform size of net shaped space on
string member 20 are used, the effect is identical to the process of dispensing cell aggregate of the size larger than the net shaped space onto support. Also, it is possible to filter out whole cell aggregate without exception by using supports with different size of net shaped space formed by string member. - Next, a fifth embodiment is explained. The fifth embodiment is to make three-dimensional cellular aggregate by net molding process.
FIG. 19 shows example of embodiment. Prepare string member which is capable to form net shaped space as shown onFIG. 19(A) , and preparemold 450 in shape as shown inFIG. 19(B) , (C).Mold 450 can be any shape, and this example hasrectangular shape mold 452.Mold 450 can be made by various process, and this can be made by plastic injection process. It is also possible to formmold 450 by laser processing, punching process. - Next, as shown on
FIG. 19(D) string member 20 is formed along the boundary ofinner space 450. Next, as shown inFIG. 19(E) , (F),cell aggregate 100 is dispensed intoinner space 452 ofmold 450 by dispenser. Then, as shown onFIG. 19(G) , lid formed bystring member 20, and placed ontomold 450. This lid prevents cell aggregate from spilling out from mold when shaken inside of solution with medium. - Next after cell aggregate fused together,
string member 20 is lifted up frommold 450 andcell aggregate 100 is removed frommold 450. Three-dimensionalcellular aggregate 460 which reflect the shape ofmold 450 is obtained by removingstring member 20. Preferably,string member 20 is made with non-adherent material, or its surface is coated by non-adherent material, so that removal ofstring member 20 fromcell aggregate 100 is easier. - Next, sixth embodiment of present invention is explained. The sixth embodiment is to apply the use of support of present invention to three-dimensional dispenser. As shown on
FIG. 19A , automated-dispenser comprisestage 470, reference guide 472 (x direction) and guide 474 (y direction), a pair of movingtower 480 which moves in x direction, bridgingmember 482 which connect betweentower 480 in y direction, slidingmember 484 which is movable to Y and Z direction,dispenser 490 andplunger 492 attached on slidingmember 484. -
Dispenser 490 will be filled withcell aggregate 100, asplunger 492 is actuated in Z direction so thatcell aggregate 100 is extruded from tip ofdispenser 490. Automated dispenser is pre-programmed of the shape ofsupport 1 and the initial filling point of cell aggregate, and automated dispenser scan in X, Y, Z direction according to the three-dimensional data of three-dimensional cellular structure to be made. - After
support 1 is positioned according toreference guide 472 and 474,dispenser 490 scan in direction of X and Y, simultaneously plunger 492 is actuated, cell aggregate is extruded onto support from tip ofdispenser 490. When one support dispensing is completed, another support is layered and again cell aggregate is dispensed according to three-dimensional data. This embodiment enable fast dispensing of cell aggregate onto supports. - Next, several ways to fabricate support are explained.
Support 1 comprises, for example,rectangular frame 10.Support 1 can be any shape and size, and space surrounded byframe 10 is further divided into smaller spaces bystring member 20.String Member 20 consists of thread or needle shaped member and end ofstring member 20 is adhered or fixed in other way to frame. - Another way to fabricate support is to use semiconductor lithography process to form multiple spaces onto thin plastic or metal material.
FIG. 20 shows schematic cross-sectional view of the process. As shown inFIG. 20(A) , placethin material 510 which will become support ontoresin film 500 such as UV cured type, and patternedmusk 520 is formed by photo-lithography process,Musk 520 is designed so that gap distance Px, Py form matrix shape. - Next
FIG. 20(B) shows that exposed areas ofthin material 510 are removed by an etching process. Anisotropic etching process is preferred for accuracy. Etching process can be either wet or dry process. Next, as shown inFIG. 20(C) ,musk 520 is removed and then as shown inFIG. 20(D) resin film 500 is removed by exposing to UV light. - By these processes,
integrated support 1 comprisingframe 10 andstring member 20 as one is fabricated. Above mentioned example used photo lithography process, butmusk 520 fabrication method can be other method such as laser processing. - Furthermore as other way of fabrication, cavity with gap distance Px, Py can be formed by laser processing onto thin material to form support. Also, punching process can be used to form cavity onto thin material by applying embossing member with Px, Py shaped pattern. Also, 3D printer can be used to from integrated support with frame and string member as one by resin materials.
- Other way to fabricate support,
string member 20 of support can be formed by bonding wire.FIG. 20A is schematic cross-sectional view when string member is formed by bonding wires. As preferred example,base 550 is prepared first.Base 550 is made with metal material such as stainless steel.Base 520 compriseouter frame 552 and center net area which comprise multiple opening 524. As an example, opening 554 can be made by etching process onbase 550. Onouter frame 552,frame 560A and 560C with level step in its inside are formed.Frame 560A and 560C are equivalent to frame 10A, 10C ofFIG. 1 , respectively. On this example.Frame 560A and 560C possess 4 level steps equivalent to 4 layers of supports. On layer 1-1, bonding wire B-1 runs in X and Y directions, and on layer 1-2 bonding wire B-2 runs in X and Y directions, on layer 1-3 bonding wire B-3 runs in X and Y directions, on layer 1-4, bonding wire B-4 runs in X and Y directions. This structure is practically same structure as 5 supports are layered. - It is noted that the gap distance of bonding wire B-1˜B-4 in X and Y direction does not have to be uniform. Similarly gap distance of
opening 554 in X and Y direction does not have to be uniform. The gap distance can be various as explained inFIG. 11 . Furthermore if necessary,top lid 570 can be used. This top lid can be same asbase 550. -
FIG. 21 is a block chart of electrical structure of equipment used for three-dimensional cellular structure fabrication.Equipment 600 compriseinterface 610 which enable input from operator and connection between equipment and peripheral equipment,memory 620 which stores data and program,controller 630, andactuator 640 which drivesdispenser 200.Memory 620 comprise program for fabrication process to fabricate three-dimensional cellular structure,controller 630 conduct the program to fabricate three-dimensional cellular structure. As a preferable example,memory 620 stores 3D data of three-dimensional cellular structure,controller 630 controls scanning track ofdispenser 200. This means that the dispenser provides the shape of cell aggregates on the support based on 3D data. In this case, the shape of each layer of support is determined by 3D data. For example, when 3D data is corn shape,dispenser 200 deliver cell aggregate in different shapes, which is smaller and smaller, on each layer. Also,actuator 640 moves stage to X and Y direction to dispense cell aggregate onto supports. - Next, the seventh embodiment is described.
FIG. 22 shows how 3D support is made by 3D Printer. In this embodiment, this 3D support is called asmold 700.Mold 700 is made with non-toxic material to human being. Preferably,mold 700 is made with material such as polycarbonate which has high melting temperature for high temperature sterilization. Also preferably,mold 700 is coated with non-adherent material to prevent cell adhesion to mold. -
Mold 700 comprise, as shown inFIG. 22(A) ,upper part 710 andlower part 720.Upper part 710 andlower part 720 possess net shaped area where cell aggregates are held and they are made by 3D printer. When cell aggregate is filled in mold and cell aggregate is fused, in order to remove three-dimensional cellular structure frommold 700,mold 700 is separated toupper part 710 andlower part 720 at cutting position Dv. -
Upper part 710 comprises top and side members. Multiple fillingholes 702 are connected to the inner space on the top member. Also, a side ofupper part 710 hasmultiple circulation holes 704 for medium flow.Upper part 710 comprisescolumn support 706 which extend from top, andmultiple support columns 706 are connected to upper net shapedmembers 708 which form three-dimensional space.Lower part 720comprise column support 714 which extend from bottom, andmultiple support column 714 are connected to lower net shapedmember 716 which form three-dimensional space -
Cell aggregate 100 is filled in through fillinghole 702. One preferable example, the gap distance of upper net shapedmember 708 is larger than the size of cell aggregate but the gap distance of lower net shapedmember 716 is smaller than the size of cell aggregate so that cell aggregate pass through upper net shapedmember 708 and trapped by lower net shapedmember 716. It needed to be noted that this is one example and gap distance of upper net shapedmember 708 and lower net shaped member can be the same. - Next, as shown in
FIG. 22(B) ,mold 700 with cell aggregates filled is soaked incontainer 720 filled withmedium 730. By applying movement by shaker, medium 730 shall circulate through fillinghole 702 and circulating 704 and 714, which enable effective culture of cells. When maturation is completed, as shown inholes FIG. 22(C) ,mold 700 is separated toupper part 710 andlower part 720, and three-dimensional cellular structure is obtained. -
String member 20 used by embodiment 1-6 are made of either adherent or non-adherent materials. Preferably,string member 20 is made with non-adherent material for easy removal, coated with non-adherent material otherwise. - Cell aggregate used by embodiment 1-3 are consists of either single cell type or multiple cell types. When multiple cell types are used, obtained three-dimensional cellular structure comprise multiple cell type.
- Three-dimensional cellular structure made by embodiment 1-5 are used for medical and research purpose, as well as potential application of joint regeneration, toxicity screening, cancer research, neural regeneration, cardiovascular regeneration, as such.
- Above, many embodiments are described, but should be noted that present invention is not limited to these embodiments and shall be modified within the gist of present invention as claimed in this document.
Claims (39)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16/677,735 US20200071662A1 (en) | 2016-09-13 | 2019-11-08 | Manufacturing Method and Device for Three-Dimensional Engineered Tissue |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP2016/076987 WO2018051415A1 (en) | 2016-09-13 | 2016-09-13 | Method for producing three-dimensional cell structure and support used for same |
| US15/920,082 US10513684B2 (en) | 2016-09-13 | 2018-03-13 | Manufacturing method and device for three-dimensional engineered tissue |
| US16/677,735 US20200071662A1 (en) | 2016-09-13 | 2019-11-08 | Manufacturing Method and Device for Three-Dimensional Engineered Tissue |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US15/920,082 Continuation US10513684B2 (en) | 2016-09-13 | 2018-03-13 | Manufacturing method and device for three-dimensional engineered tissue |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20200071662A1 true US20200071662A1 (en) | 2020-03-05 |
Family
ID=60940128
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US15/920,082 Active 2036-12-28 US10513684B2 (en) | 2016-09-13 | 2018-03-13 | Manufacturing method and device for three-dimensional engineered tissue |
| US16/677,735 Abandoned US20200071662A1 (en) | 2016-09-13 | 2019-11-08 | Manufacturing Method and Device for Three-Dimensional Engineered Tissue |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US15/920,082 Active 2036-12-28 US10513684B2 (en) | 2016-09-13 | 2018-03-13 | Manufacturing method and device for three-dimensional engineered tissue |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US10513684B2 (en) |
| EP (1) | EP3514227B1 (en) |
| JP (1) | JP6256853B1 (en) |
| DK (1) | DK3514227T3 (en) |
| WO (1) | WO2018051415A1 (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111770987A (en) * | 2018-02-27 | 2020-10-13 | 三维生物科技有限公司 | Rack Loaders for Bioreactors |
| JP7041346B2 (en) * | 2018-02-28 | 2022-03-24 | 澁谷工業株式会社 | Cell culture method using gelatin support |
| KR102065343B1 (en) * | 2018-05-11 | 2020-01-13 | 한국화학연구원 | Method and Device for three-dimensional cell co-culture |
| US20200010799A1 (en) * | 2018-07-09 | 2020-01-09 | Wisconsin Alumni Research Foundation | Scaffold for in vitro modeling and transplantation therapy of photoreceptors |
| KR102489607B1 (en) * | 2018-10-24 | 2023-01-17 | 포항공과대학교 산학협력단 | Method of manufacturing cell spheroid using three-dimensional printing method |
| US11692161B2 (en) | 2019-02-05 | 2023-07-04 | Corning Incorporated | Packed-bed bioreactor systems and methods of using the same |
| JP2020198794A (en) * | 2019-06-07 | 2020-12-17 | ティシューバイネット株式会社 | Culture mold, shaking culture vessel, culture system, coculture method, fertilized egg, and endometrium cell |
| US11118151B2 (en) | 2019-11-05 | 2021-09-14 | Corning Incorporated | Fixed bed bioreactor and methods of using the same |
| JP2022032393A (en) * | 2020-08-12 | 2022-02-25 | ティシューバイネット株式会社 | Artificial skin having epithelial structure and method for producing the same |
| JP7471579B1 (en) | 2023-04-28 | 2024-04-22 | ティシューバイネット株式会社 | Method for producing a three-dimensional cell structure |
| WO2025063900A1 (en) * | 2023-09-21 | 2025-03-27 | Agency For Science, Technology And Research | A membrane holding device for producing a tissue membrane, a method of producing a tissue membrane, and a tissue membrane construct |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7147826B2 (en) * | 2001-10-12 | 2006-12-12 | Becton Dickinson And Company | Method and apparatus for transporting biological samples |
| EP1450951B1 (en) | 2001-10-12 | 2017-05-10 | Becton, Dickinson and Company | Basket apparatus for transporting biological samples |
| JP3733127B2 (en) * | 2003-04-24 | 2006-01-11 | ナノフォトン株式会社 | CELL CULTURE METHOD, CELL CULTURE DEVICE, 3D FRAME FORMATION METHOD USED FOR CELL TISSUE CULTURE, 3D FRAME FORMATION DEVICE USED FOR CELL TISSUE CULTURE, AND 3D FRAME USED FOR CELL TISSUE CULTURE |
| JP4122280B2 (en) | 2003-05-15 | 2008-07-23 | 幸英 岩本 | Manufacturing method of tissue plug |
| WO2005047496A1 (en) | 2003-11-14 | 2005-05-26 | Keio University | Cell culture method, three-dimensional cell culture method, three-dimensional tissue, artificial organ and tissue transplantation method |
| WO2005081970A2 (en) | 2004-02-24 | 2005-09-09 | The Curators Of The University Of Missouri | Self-assembling cell aggregates and methods of making engineered tissue using the same |
| CN101245313A (en) * | 2007-02-13 | 2008-08-20 | 刘青 | Three dimensional cell culture construct and apparatus for its making |
| US8198086B2 (en) * | 2007-03-30 | 2012-06-12 | Kyushu University, National University Corporation | Method for production of three-dimensional structure of cells |
| EP2626413B8 (en) * | 2007-05-11 | 2016-07-20 | Dai Nippon Printing Co., Ltd. | Cell sheet having good dimensional stability, method for production thereof, and cell culture carrier for use in the method |
| WO2010069080A1 (en) * | 2008-12-19 | 2010-06-24 | Stemcell Technologies Inc. | Filter apparatus and filter plate system |
| JPWO2013073672A1 (en) * | 2011-11-18 | 2015-04-02 | 国立大学法人佐賀大学 | Apparatus for producing a support for producing a three-dimensional structure of a cell |
| EP2664367A1 (en) * | 2012-05-15 | 2013-11-20 | Miltenyi Biotec GmbH | Stackable cell strainer |
| JP2015057961A (en) * | 2013-09-17 | 2015-03-30 | デュプロ精工株式会社 | Method and device for making three-dimensional structure |
| CN113265332A (en) * | 2014-10-29 | 2021-08-17 | 康宁股份有限公司 | Method and apparatus for generating and culturing 3D cell aggregates |
| JP6593589B2 (en) * | 2015-09-30 | 2019-10-23 | 澁谷工業株式会社 | Cell mass sheet preparation method and cell mass sheet |
| JP6882658B2 (en) * | 2015-10-29 | 2021-06-02 | 澁谷工業株式会社 | Method and apparatus for preparing a cell aggregate structure |
| JP6822769B2 (en) | 2016-02-29 | 2021-01-27 | 米満 吉和 | Regularly arranged spheroids of the same size and their use |
-
2016
- 2016-09-13 DK DK16916200.5T patent/DK3514227T3/en active
- 2016-09-13 JP JP2017536372A patent/JP6256853B1/en active Active
- 2016-09-13 EP EP16916200.5A patent/EP3514227B1/en active Active
- 2016-09-13 WO PCT/JP2016/076987 patent/WO2018051415A1/en not_active Ceased
-
2018
- 2018-03-13 US US15/920,082 patent/US10513684B2/en active Active
-
2019
- 2019-11-08 US US16/677,735 patent/US20200071662A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP3514227A1 (en) | 2019-07-24 |
| US10513684B2 (en) | 2019-12-24 |
| US20180223252A1 (en) | 2018-08-09 |
| DK3514227T3 (en) | 2020-09-14 |
| WO2018051415A1 (en) | 2018-03-22 |
| EP3514227A4 (en) | 2019-12-25 |
| JPWO2018051415A1 (en) | 2018-09-13 |
| EP3514227B1 (en) | 2020-06-10 |
| JP6256853B1 (en) | 2018-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10513684B2 (en) | Manufacturing method and device for three-dimensional engineered tissue | |
| US20240218321A1 (en) | Self-assembling cell aggregates and methods of making engineered tissue using the same | |
| Pati et al. | 3D bioprinting of tissue/organ models | |
| CN105659089B (en) | Automated devices, systems and methods for tissue manufacturing | |
| EP3122559B1 (en) | Methods, devices, and systems for the fabrication of materials and tissues utilizing electromagnetic radiation | |
| WO2018026172A1 (en) | Cell culture obtained using integrated three-dimensional cell printing technique, and method for preparing same | |
| EP2580313B1 (en) | Apparatus, kits and methods for the production of biomimetic constructs | |
| JP2016093149A (en) | Cell culture apparatus, and cell culture method | |
| CN113302041A (en) | Compositions and methods for printing three-dimensional structures corresponding to biological materials | |
| JP7441521B2 (en) | Cell holding and transport device | |
| JP6439223B1 (en) | Cell structure manufacturing apparatus, manufacturing system, and manufacturing method | |
| KR102489607B1 (en) | Method of manufacturing cell spheroid using three-dimensional printing method | |
| CN119175879A (en) | Multi-scale controllable three-dimensional tissue construction process method and device | |
| EP4048331B1 (en) | Methods and systems for generating three-dimensional biological structures | |
| Le et al. | A platform for Bioengineering Tissue Membranes from cell spheroids | |
| Baptista | Breathing life into in vitro models: Exploring the respiratory landscape of bioinspired culture substrates for pulmonary research | |
| Bova | Biostampa 3D di costrutti cellularizzati in vitro | |
| Bakker | Using 3D bio-printing for the development of human organs and tissues | |
| Graham et al. | The design and implementation of a 3D-bioprinter | |
| Cabral | Micro-Patterning Cells on Polyacrylamide Hydrogels | |
| Mohanty | Developing 3D microstructures for tissue engineering |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: ADVISORY ACTION MAILED |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |